Company intelligence
Connexin Therapeutics Ltd.
Connexin Therapeutics is developing drugs which protect vision in patients with glaucoma and other eye diseases.
Biotechnology Research
Cambridge, GB
2 employees
1 public signals
About Connexin Therapeutics Ltd.
Connexin Therapeutics is developing small molecule drugs which protect and preserve vision in glaucoma, retinopathies, and various corneal conditions. We are raising our Seed Round of £10 million to advance our programs into IND.
Verified activity
Signals from Connexin Therapeutics Ltd.
1 published signal